Table 2 Clinical features of enrolled patients
From: Perianal Crohn’s disease and hidradenitis suppurativa: a possible common immunological scenario
Patient | Sex/age at surgery (years) | Smoker | Age at CD diagnosis (years) | Age at perianal fistula diagnosis (years) | CD localization/type of perianal fistula | Age at HS diagnosis (years) | Type of HS | Previous therapy |
|---|---|---|---|---|---|---|---|---|
1 | F/49 | Yes | 21 | 20 | Ileal/transsphincteric | 33 | Inguinal, recurrent | Steroid |
Mesalamine | ||||||||
Azatioprine | ||||||||
Infliximab | ||||||||
2 | F/26 | Yes | 22 | 26 | Colic/Ano-vaginal | 26 | Axillary | Steroid |
Mesalamine | ||||||||
Adalimumab | ||||||||
3 | F/42 | No | 26 | 33 | Ileal/transsphincteric | 40 | Axillary | Steroid |
Mesalamine | ||||||||
Azatioprine | ||||||||
Infliximab |